| Title: | Association of metabolic vulnerability index with various chronic liver diseases and mortality: a large prospective cohort study |
| Journal: | BMC Gastroenterology |
| Published: | 23 May 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/42177400/ |
| DOI: | https://doi.org/10.1186/s12876-026-04932-0 |
Publication 19928
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundThe association between metabolic vulnerability index (MVX), a composite biomarker integrating inflammatory and metabolic pathways, and chronic liver diseases (CLDs) is still unclear.MethodsThis prospective cohort study included 255,171 participants from the UK Biobank, with a median follow-up period of 13.71 years. Multivariable-adjusted cox proportional hazards models, restricted cubic splines (RCS) and sensitivity analyses were used to evaluate the association between MVX and CLDs.ResultsThis study showed that higher levels of MVX (Q4 vs Q1) significantly increased the risk of CLDs after adjusted by socio-demographic and health status factors (all P < 0.05): cirrhosis (HR = 1.60, 95%CI:1.38-1.86), alcoholic-related liver disease (HR = 1.34, 95%CI:1.07-1.68), autoimmune liver disease (HR = 1.35, 95%CI:1.12-1.62), liver and biliary tract cancer (HR = 1.32, 95%CI:1.05-1.66), liver disease-related death (HR = 2.11, 95%CI:1.59-2.80), and all-cause mortality (HR = 1.17, 95%CI:1.13-1.21). No association was found between MVX and viral hepatitis. RCS and threshold analysis showed a reverse L-shaped association between MVX and cirrhosis and liver-related deaths, a linearly increasing association with AILD and LBC, and a J-shaped association with ALD and all-cause mortality. Subgroups analysis and sensitivity analyses demonstrated stable correlation between MVX and CLDs and death events.ConclusionMVX is a promising indicator for independently predicting CLD events, liver-related mortality, and all-cause mortality. As a marker of metabolic-inflammatory dysregulation, MVX may enable early identification of high-risk individuals for targeted primary prevention of CLDs.</p>
8 Authors
- Zihan Qin
- Kaiqi Yang
- Zheng Liang
- Le Gao
- Yifei Liu
- Jiafei Peng
- Hongtao Wei
- Shutian Zhang
1 Application
| Application ID | Title |
|---|---|
| 698215 | The association between specific gastrointestinal disorders and autoimmune diseases |
Enabling scientific discoveries that improve human health